Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 13:12:1003895.
doi: 10.3389/fonc.2022.1003895. eCollection 2022.

Clinicopathological characteristics of gastrointestinal schwannomas: A retrospective analysis of 78 cases

Affiliations

Clinicopathological characteristics of gastrointestinal schwannomas: A retrospective analysis of 78 cases

Hailing Peng et al. Front Oncol. .

Abstract

Introduction: Schwannomas are tumors arising from Schwan cells of the neural sheath, which rarely occur in the gastrointestinal tract. The aim of the present study was to analyze the clinicopathological features and treatment outcomes of gastrointestinal schwannomas (GISs).

Methods: Patients who were diagnosed with GISs in our hospital from January 2010 to December 2021 were selected. Data about demographic characteristics, clinical symptoms, treatment methods and outcomes, pathological results, and follow-up results were retrospectively collected and analyzed.

Results: A total of 78 patients with 79 GISs were included, the female-to-male ratio was 55:23, and the average age was 52.12 ± 12.26 years. One-third (26/78) of the patients were asymptomatic. A total of 79 GISs were removed, and the average size was 3.63 ± 2.03 cm (range, 0.3-10 cm). As for tumor location, 54 GISs were located in the stomach, 14 in the esophagus, 2 in the duodenum, 6 in the colorectum (4 in the colon and 2 in the rectum), and the other 3 in the small intestine. A total of 23 and 55 patients underwent endoscopic and surgical resections, respectively. Compared with surgical resection, endoscopic resection is associated with a smaller diameter, lower cost, and shorter hospital stay. Pathological results revealed that S100 was positive in all the GISs. No recurrence was noticed during a median follow-up of 45 months (range, 6-148 months).

Conclusion: GISs are rare gastrointestinal tumors with favorable prognoses, which are most commonly seen in the stomach and diagnosed by pathological findings with immunohistochemical staining. Surgical resection remains the standard method for removing GISs, while endoscopic resection may serve as an alternative method for selected patients with GISs and may be attempted in GISs with a diameter of <3 cm and no signs of malignancy.

Keywords: endoscopic therapy; gastrointestinal schwannomas; prognosis; submucosal tumors; surgical treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Case illustration of an esophageal schwannoma. (A) A submucosal tumor was seen in the esophagus. (B) Endoscopic ultrasonography revealed that the tumor originated from the muscularis propria layer with heterogeneous echo. (C) The tumor was removed by submucosal tunneling endoscopic resection, and we could see the tumor in the submucosal tunnel. (D) The resected tumor. (E) Histological results revealed spindle cell tumors. (F) Immunohistochemical staining of S100 was positive, consisting of schwannoma.
Figure 2
Figure 2
Case illustration of gastric schwannoma. (A) Computed tomography showed a protruding lesion in the stomach. (B) The tumor was removed by surgical resection, and this was the resected tumor. (C) Histological results revealed spindle cell tumors. (D) Immunohistochemical staining of S100 was positive, consisting of schwannoma.

Similar articles

Cited by

References

    1. Qi ZP, Li QL, Zhong YS, Zhou PH. [Interpretation of the Chinese consensus on endoscopic diagnosis and management of gastrointestinal submucosal tumors (version 2018)]. Zhonghua Wei Chang Wai Ke Za Zhi (2019) 22(7):609–12. doi: 10.3760/cma.j.issn.1671-0274.2019.07.002 - DOI - PubMed
    1. Nishida T, Hirota S. Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopathol (2000) 15(4):1293–301. doi: 10.14670/HH-15.1293 - DOI - PubMed
    1. Qi Z, Yang N, Pi M, Yu W. Current status of the diagnosis and treatment of gastrointestinal schwannoma. Oncol Lett (2021) 21(5):384. doi: 10.3892/ol.2021.12645 - DOI - PMC - PubMed
    1. Lauricella S, Valeri S, Masciana G, Gallo IF, Mazzotta E, Pagnoni C, et al. . What about gastric schwannoma? a review article. J Gastrointest Cancer (2021) 52(1):57–67. doi: 10.1007/s12029-020-00456-2 - DOI - PubMed
    1. Daimaru Y, Kido H, Hashimoto H, Enjoji M. Benign schwannoma of the gastrointestinal tract: a clinicopathologic and immunohistochemical study. Hum Pathol (1988) 19(3):257–64. doi: 10.1016/s0046-8177(88)80518-5 - DOI - PubMed